H.R. 7166 · 117th Congress
Make Medicine in America Again Act
- Stage
- In committee
- Sponsor
- Alexander Mooney
- Introduced
- 2022-03-18
- Latest action
- 2022-03-18 · Introduced in House
Summary
Make Medicine in America Again Act
This bill provides tax incentives for the manufacture of pharmaceutical property, equipment, buildings, or facilities in the United States. Specifically it allows bonus depreciation for such property and a business-related tax credit for 50% of expenditures for (1) wages for services performed in a U.S. pharmaceutical manufacturing business, (2) the tangible personal property of such a business, and (3) any direct or indirect costs paid or incurred in a U.S. pharmaceutical manufacturing business.